Presentation EuroPCR 2024 Hybrid coronary revascularisation–10-year clinical outcomes of the prospective randomised study. Presenter: Mateusz Tajstra May 15, 2024 REGISTER for free or LOG IN to view this content Coronary Cardiac Surgery Presentation EuroPCR 2024 Up Next Presentation EuroPCR 2024 Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study Presenter: Bernardo Cortese May 14, 2024 More slides + Presentation EuroPCR 2024 Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes Presenter: Alexandre Abizaid May 14, 2024 Presentation EuroPCR 2024 First report of an IDE pivotal study of a dedicated splitting device during TAVR Presenter: Danny Dvir May 15, 2024 We Recommend
Presentation EuroPCR 2024 Sirolimus vs paclitaxel DCB. A logistic regression analysis of EASTBOURNE and PEARL multicentre study Presenter: Bernardo Cortese May 14, 2024
Presentation EuroPCR 2024 Site-specific antithrombotic therapy: DESyne BDS Plus study 12-month outcomes Presenter: Alexandre Abizaid May 14, 2024
Presentation EuroPCR 2024 First report of an IDE pivotal study of a dedicated splitting device during TAVR Presenter: Danny Dvir May 15, 2024